CHALLENGE OR OPPORTUNITY? THE EXPANSION OF DRUG VOLUME-BASED PROCUREMENT IN CHINA

被引：0
|
作者：
Jin, J. [1 ]
He, Y. [2 ]
Mi, M. [2 ]
机构：
[1] IQVIA China, Shanghai 31, Peoples R China
[2] IQVIA, Shanghai 31, Peoples R China
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDG39
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [1] PRICE OFFERS IN VOLUME-BASED PROCUREMENT IN CHINA AND THEIR DETERMINANTS
    Sun, Y.
    Yang, L.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S477 - S477
  • [2] MONITORING DRUG VOLUME-BASED PROCUREMENT IN SHANGHAI, CHINA: A DATA-DRIVEN SITUATION ANALYSIS
    Xu, Q.
    Li, L.
    Li, K.
    Yan, W.
    Zhang, S.
    Liu, B.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S216 - S216
  • [3] Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin
    Zhao, Boya
    Wu, Jing
    [J]. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2023, 12 (01)
  • [4] OPTIMIZING CHINA BMI FUNDS THROUGH DRUG VOLUME-BASED PROCUREMENT: UNDERSTANDING THE RESULT, IMPACT AND CHALLENGES
    He, Y.
    Liu, R. X.
    Mi, F.
    [J]. VALUE IN HEALTH, 2019, 22 : S605 - S605
  • [5] Does China's national volume-based drug procurement policy promote or hinder pharmaceutical innovation?
    Li, Xiujuan
    Xu, Jiachun
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [6] Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China
    Yuan, Jing
    Lu, Z. Kevinff
    Xiong, Xiaomo
    Jiang, Bin
    [J]. BMJ GLOBAL HEALTH, 2021, 6 (09):
  • [7] Improving access to medicines and beyond: the national volume-based procurement policy in China
    Zhu, Zheng
    Wang, Quan
    Sun, Qiang
    Lexchin, Joel
    Yang, Li
    [J]. BMJ GLOBAL HEALTH, 2023, 8 (07):
  • [8] Challenges and countermeasures for China's centralised volume-based procurement policy in healthcare
    Chang, Qi
    Tian, Yihui
    Gao, Lingyun
    Xia, Nan
    [J]. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2024, 39 (05): : 1330 - 1349
  • [9] Administrative regulation-informed analysis of the developmental path of national volume-based procurement to improve drug accessibility in China
    Lu, Songxin
    Liu, Xiangdong
    Huang, Zhengzong
    Zhou, Zhiheng
    Feng, Zehua
    [J]. FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [10] SHOULD VOLUME-BASED PROCUREMENT PRICE OF COMPARATOR BE REFERENCED FOR INNOVATIVE DRUGS IN NATIONAL REIMBURSEMENT DRUG LIST NEGOTIATION IN CHINA?
    Wu, J.
    Liu, J.
    Ming, J.
    Qu, S.
    Wei, T.
    Zhu, L.
    Chen, J.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S220 - S220
12345